Dialog Box


Our board

Ovarian Cancer Australia’s board of directors dedicates a huge amount of both professional and personal time and energy to our vision.

Marina Go

Chair

An independent non-executive director on the boards of Energy Australia, 7-Eleven, Autosports Group,  O’Connell Street Associates and Pro-Pac, and named by Boss Magazine as one of the 20 True Leaders of 2016, Marina’s executive media career focused on creating and building commercially successful brands that connect deeply with consumer groups across digital and print channels.

A mother to two sons, Marina has a personal connection to ovarian cancer. Her husband’s family carry the BRCA1 gene mutation and he was a cousin of Ovarian Cancer Australia founder Lynda Gibson.

Marina holds a Bachelor of Arts (Mass Comm) Macquarie University, Master of  Business Administration, AGSM UNSW Business School and authored 'Break Through - 20 Success Strategies for Female Leaders'.  

Chair of:  Super Netball Commission, The Walkley Foundation and The Advisory Board for the Centre for Media Transition at University of Technology Sydney. 


Adjunct Professor Juliet Bourke

Director

Juliet Bourke is an Adjunct Professor in the School of Management and Governance, Business School of UNSW, Chair of the AICD 30% Club Education Working Group, and a board member on the Global Institute for Women’s Leadership King’s College London (established and chaired by former Prime Minister Julia Gillard AC), and qChange (a US based tech-start up).  

Formerly a partner at Deloitte (2011-2020), and the co-founder of Aequus Partners (2000-2011), Juliet has advised over 200 global organisations on people and culture issues, including American Airlines, APRA, the Australian Army, BHP, Gilead Sciences, Johson & Johnson, Macquarie Group, Qantas, the RBA, Toyota, the United Nations and Woodside. She has served on three Diversity Councils, namely for the RBA, the Australian Navy and Deloitte Australia. Juliet started her career as a lawyer, firstly working in criminal law for the Commonwealth Director of Prosecutions and then in employment law. 

Juliet is a TEDx speaker, a 2019 Australian Financial Review Top 100 Women of Influence and is well known for her thought leadership on diversity and inclusion. She has published in the Harvard Business Review, the Australian Financial Review and The Guardian. Her most recent book (published by the Australian Institute of Company Directors) is “Which two heads are better than one? The extraordinary power of diversity of thinking and inclusive leadership” (2021)).  

Juliet holds a BA (Psychology Major), LLB, LLM (with Hons) and is a final year PhD candidate (Business School, Brunel University London).   


Marco D'Avino

Director

Marco D’Avino is a partner in Bain & Company’s Sydney office. He is a leader in the Bain Accelerated Transformation practice and an expert in the Industrial Goods & Services and Performance Improvement practices.

Marco has extensive experience in industrials, resources and manufacturing. Over the course of his career, he has worked with multiple executive teams to address a variety of business challenges, including large transformations, performance improvement, organisation and operations management. Marco has particular expertise in managing and driving large scale transformations, leveraging agile and Scrum methodologies.

He holds a PhD in Industrial Engineering, Master’s in Management Engineering and Bachelor in Management Engineering from Tor Vergata University, as well as an International Master’s in Manufacturing Management from Linköpings Universitet


Jo-Ann Hicks

Director

Jo-Ann is a leading digital and ecommerce professional with more than 16 years’ experience in the online and technology space.

Jo-Ann is currently the Head of Digital Marketplaces at BIG W within the Woolworths Group. Prior to the Woolworths Group, Jo-Ann was the Chief Operating Officer of Mable (mable.com.au).

Jo-Ann has held various executive and senior management roles for leading Australian online companies including The ICONIC, Seek Ltd and Mi9. Jo-Ann also spent over 5 years with eBay Australia & New Zealand in multiple executive roles including Head of Strategy and Head of Fashion. She has a management consulting background, beginning her career with The Boston Consulting Group. Jo-Ann has an MBA from Melbourne Business School and was awarded the MBS Foundation Award of Distinction (Dean’s List).

Jo-Ann lives in Sydney and joined the board of Ovarian Cancer Australia in 2014.


Professor Ian Jacobs

Director

Professor Ian Jacobs has been President and Vice-Chancellor of UNSW Sydney since February 2015. Prior to this, he was based in the UK as Dean of Medicine at University College London from 2009-11 and Vice President of the University of Manchester from 2011-15.

He qualified in medicine at Cambridge University and the University of London before specialising in surgical treatment of women’s cancers at St Bartholomew’s Hospital and University College Hospital in London. For the last 30 years Professor Jacobs has led a research team working on early detection and risk prediction of cancer, with a particular focus on screening for ovarian cancer.

Since joining UNSW Sydney he has held a number of additional roles in Australia including: Honorary Senior Principal Research Fellow of the Garvan Institute; Board member of Research Australia; Chair of the Australian Conservation Foundation’s Leadership Forum for Energy Transition; Board member of the Business/Higher Education Round Table (BHERT); Board member of The Conversation; Chair of the Sydney Partnership for Health Education, Research and Enterprise (SPHERE); now Board member of Ovarian Cancer Australia; and most recently Chair of the Group of Eight universities.


Meghan Speers

Director

Meghan is a partner at Deloitte. She is a Chartered Accountant and solicitor and an ovarian cancer survivor, having been diagnosed at 29 years of age. A mother of two, Meghan has been actively involved in raising awareness about ovarian cancer, working closely with Ovarian Cancer Australia, for more than 10 years.

Meghan sees joining the Board of Ovarian Cancer Australia as a chance to give back to an organisation that provided so much support and ensured she didn’t battle ovarian cancer alone.  Her ambition is to bring her commercial business expertise with a consumer’s insight and to assist Ovarian Cancer Australia to achieve its bold 2025 vision to reduce the incidence and improve the survival rates of ovarian cancer.


Marise Maltman

Director

Marise Maltman is a partner at Deloitte and a chartered accountant with a career that spans 3 decades locally in Australia, and globally in South Africa and England.   

Marise's international experience working with complex organisations will be beneficial as Ovarian Cancer Australia continues to navigate the challenging and exciting changing environment.  

While Marise started as an auditor, she changed focus in 2012 using deep problem-solving and analytical skills to work with companies to enable change (often from ‘developing’ to leading practices), resolve complex business issues and lead finance transformation. Being an auditor for 20+ years and working in various industries provided a great springboard to something new. 

Marise has a solid track record working with executives in various industries resolving intricate finance and business issues using years of varied experience to consistently deliver successful outcomes and manage multiple stakeholders. In her current role she works directly with key finance executives in some of Australia’s most iconic companies to help improve the effectiveness of their finance function in the context of business challenges to facilitate and create effective solutions and efficiencies.


Professor Karen Strickland

Director

Karen Strickland is Professor of Nursing at the University of Canberra. She is an experienced academic nurse leader with significant clinical, academic and research experience across the health, higher education, and social service sectors.

Karen trained as a nurse in Edinburgh, where she worked in various surgical units and Marie Curie Cancer Care Hospice, before moving into academic positions. Karen’s research is focused on the lived experiences of people affected by cancer, seeking to understand how health care professionals can better support people and their families who are affected by cancer. Karen is recognised as an expert in the fields of cancer and palliative care nursing through various appointments including as invited member of the Professional Advisory Council of the Cancer Nurses Society of Australia and two Visiting Professor appointments with international universities in New Zealand and Scotland.  

Karen has held a number of board level appointments including Board Chair to Canberra College in the ACT, and previously as Non-Executive Director of Alcohol and Drugs Action, Aberdeen, Scotland. Within the University of Canberra, she is a Professorial member of the University Academic Board and Education Committees. Karen holds statutory appointments as member of the Nursing and Midwifery Board of Australia ACT Board, and as Council of Deans of Nursing and Midwifery member of the Commonwealth Nursing and Midwifery Strategic Reference Group. 

Karen is a registered nurse and holds a PhD in Nursing from Edinburgh Napier University (Scotland) as well as being a Fellow of the European Academy of Nursing and the Higher Education Academy (UK).  

Donate